Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
Go back to Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.83 -0.82 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.65 | 52 Week High | $77.12 | |||
| Open | $64.13 | 52 Week Low | $49.03 | |||
| Day High | $64.33 | P/E | 41.45 | |||
| Day Low | $63.35 | EPS | $1.54 | |||
| Volume | 7,529,798 | |||||
| TORREYPINES THERA (NASDAQ: TPTX) | Delayed: 76.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.01 | 52 Week High | $0.69 | |||
| Open | $0.10 | 52 Week Low | $0.07 | |||
| Day High | $76.01 | P/E | N/A | |||
| Day Low | $76.01 | EPS | $-0.90 | |||
| Volume | 11,307 | |||||
